Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on ...

Patients who get blood work through Labcorp can now receive AI-generated plain-language explanations of their results inside ...

LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds ...

Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

The AI juggernaut is all-in on the healthcare industry, launching three new products in the last six months. But it needs to ...

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

Shares of Labcorp Holdings Inc. LH rallied 1.39% to $283.88 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.22% to 7,483 ...

Detailed price information for Laboratory Corp of America (LH-N) from The Globe and Mail including charting and trades.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

A healthcare company is preparing to pay $35,000,000 to settle a class action lawsuit over a cybersecurity incident that ...

Also served as the Representative Director and General Manager of Labcorp Laboratories Japan and Chief Executive Officer (CEO) of the Global Health Innovative Technology (GHIT) Fund, driving ...